These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21692240)

  • 1. AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation.
    Jose C; Hébert-Chatelain E; Bellance N; Larendra A; Su M; Nouette-Gaulain K; Rossignol R
    Biochim Biophys Acta; 2011 Jun; 1807(6):707-18. PubMed ID: 21692240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells.
    Guan TJ; Qin FJ; Du JH; Geng L; Zhang YY; Li M
    Acta Pharmacol Sin; 2007 Dec; 28(12):1984-90. PubMed ID: 18031613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
    Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M
    Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
    Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
    J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells.
    Jung JE; Lee J; Ha J; Kim SS; Cho YH; Baik HH; Kang I
    Neurosci Lett; 2004 Jan; 354(3):197-200. PubMed ID: 14700730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-aminoimidazole-4-carboxamide ribonucleoside on the mitochondrial function and developmental ability of bovine oocytes.
    Takeo S; Abe T; Shirasuna K; Kuwayama T; Iwata H
    Theriogenology; 2015 Sep; 84(4):490-7. PubMed ID: 26001600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
    Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
    J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
    Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
    Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
    Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
    Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
    Jia F; Wu C; Chen Z; Lu G
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells.
    Tulipano G; Faggi L; Losa M; Mortini P; Spinello M; Sibilia V; Pagani F; Cocchi D; Giustina A
    Mol Cell Endocrinol; 2013 Jan; 365(2):197-206. PubMed ID: 23116772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
    Suwa M; Nakano H; Radak Z; Kumagai S
    Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
    Fediuc S; Gaidhu MP; Ceddia RB
    Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound.
    Golubitzky A; Dan P; Weissman S; Link G; Wikstrom JD; Saada A
    PLoS One; 2011; 6(10):e26883. PubMed ID: 22046392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.
    Buzzai M; Bauer DE; Jones RG; Deberardinis RJ; Hatzivassiliou G; Elstrom RL; Thompson CB
    Oncogene; 2005 Jun; 24(26):4165-73. PubMed ID: 15806154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.